A new study identified genes and genetic variations associated with 12 loci linked to risk for atrial fibrillation. The result is a genome-wide catalog to facilitate follow-on investigations.
Dr. Oussama Wazni suspects more patients with AF could benefit from early catheter ablation. So he’s leading two multicenter trials to see if his suspicions pan out.
A study shows that the first FDA-approved smartwatch healthcare accessory can effectively identify atrial fibrillation, especially with physician overview. But incorporating it into practice won’t be simple.
Middle-aged pro football retirees have a 5.5 odds ratio of prevalent atrial fibrillation compared with matched nonathlete controls from the general population, a new study finds.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Fewer than half of cardiac surgery patients with atrial fibrillation undergo concomitant ablation. Here’s why that fact is so inexplicable in 2018.
Cleveland Clinic researchers have identified biomarkers that might ultimately serve as tools for diagnostics and monitoring — or even as therapeutic targets — in patients with these concurrent conditions.
A brief case vignette showcases the clinical setting in which this increasingly popular strain-based heart imaging technique may have its greatest diagnostic and prognostic value.
The lead investigator of the STS/ACC TVT Registry study presented at ACC.17 explains why its findings suggest valve-in-valve TAVR might be the treatment of choice for inoperable and even high-risk patients.
More than 5,000 patients came to Cleveland Clinic from all over the world for electrophysiology lab procedures in 2015. This two-minute video shares a few reasons why.
Too many patients diagnosed with cryptogenic stroke haven’t had complete workups. Prolonged rhythm monitoring can help fill the gap, but there’s a role for more thorough initial evaluation too.